Literature DB >> 8506521

Extracorporeal hepatic resection for previously unresectable neoplasms.

K Yanaga1, K Kishikawa, M Shimada, S Kakizoe, H Higashi, T Nishizaki, T Matsumata, T Kanematsu, K Sugimachi.   

Abstract

BACKGROUND: Some hepatic tumors are judged inoperable solely for anatomic reasons, such as the proximity of the tumor with the major vasculature. This is because of high mortality and morbidity rates, as well as a compromised surgical margin.
METHODS: We successfully performed extracorporeal hepatic resections in two patients who were judged to have inoperable tumors by conventional means.
RESULTS: Both patients had an uneventful postoperative course, and although one patient had intrahepatic recurrence 6 months after operation, the other patient shows no recurrence 10 months later.
CONCLUSIONS: Advances in techniques for liver transplantation and organ preservation now allow resection of anatomically unresectable hepatic tumors that were deemed inoperable in the past.

Entities:  

Mesh:

Year:  1993        PMID: 8506521

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  4 in total

1.  Ex vivo liver surgery for extraadrenal pheochromocytoma.

Authors:  G Fusai; R Steinberg; A Prachalias; N D Heaton; L Spitz; M Rela
Journal:  Pediatr Surg Int       Date:  2005-11-22       Impact factor: 1.827

2.  Ex vivo and in situ resection of inferior vena cava with hepatectomy for colorectal metastases.

Authors:  J P Lodge; B J Ammori; K R Prasad; M C Bellamy
Journal:  Ann Surg       Date:  2000-04       Impact factor: 12.969

3.  In situ hypothermic perfusion of the liver versus standard total vascular exclusion for complex liver resection.

Authors:  Daniel Azoulay; Rony Eshkenazy; Paola Andreani; Denis Castaing; René Adam; Philippe Ichai; Salima Naili; Eric Vinet; Faouzi Saliba; Antoinette Lemoine; Marie-Christine Gillon; Henri Bismuth
Journal:  Ann Surg       Date:  2005-02       Impact factor: 12.969

4.  Diagnosis and treatment of inferior vena caval invasion by hepatic cancer.

Authors:  Yoshito Okada; Masato Nagino; Junichi Kamiya; Hideo Yamamoto; Naokazu Hayakawa; Yuji Nimura
Journal:  World J Surg       Date:  2003-05-13       Impact factor: 3.352

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.